Evidence map›Paper›PMID 32045981›Full record

ArticleCancers2020

Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in

Zerin Hyder, Elaine F Harkness, Emma R Woodward, Naomi L Bowers, Marta Pereira, Andrew J Wallace, Sacha J Howell, Anthony Howell, Fiona Lalloo, William G Newman and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. GermlineCancers · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. FromBreast care (Basel, Switzerland) · 2021
    Article
  18. Article
  19. GermlineCancers · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Zerin HyderManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
Elaine F HarknessDivision of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.ORCID 0000-0001-6625-7739
Emma R WoodwardManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.ORCID 0000-0002-6297-2855
Naomi L BowersManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
Marta PereiraManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
Andrew J WallaceManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
Sacha J HowellPrevent Breast Cancer Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Wythenshawe, Manchester M23 9LT, UK.
Anthony HowellPrevent Breast Cancer Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Wythenshawe, Manchester M23 9LT, UK.
Fiona LallooManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
William G NewmanManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
Miriam J SmithManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.ORCID 0000-0002-3184-0817
D Gareth EvansManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.ORCID 0000-0002-8482-5784
Manchester Academic Health Science Centre · GBManchester University NHS Foundation Trust · GBUniversity of Manchester · GB

Funding

NIHR Biomedical Research Centre Manchester NIHR BRC Manchester
6 · The paper itself

Abstract

Early age at diagnosis of breast cancer is a known risk factor for hereditary predisposition and some studies show a high risk of contralateral breast cancer in

Indexed as

BRCA1BRCA2breast cancercontralateralearly-onset breast cancerpathogenic variantsTP53

Identifiers

PMID32045981
PMCPMC7072300
OpenAlexW3005284611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.